Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patients

作者: Karin Geleijns , Bart C Jacobs , Wouter Van Rijs , Anne P Tio-Gillen , Jon D Laman

DOI: 10.1016/J.JNEUROIM.2004.01.003

关键词: TLR4AntibodySerologyImmunologyPolyneuropathyCampylobacter jejuniGuillain-Barre syndromeCampylobacter Jejuni InfectionMedicinePathogenImmunology and AllergyNeurologyClinical neurology

摘要: Guillain-Barre syndrome (GBS) is an acute immune-mediated polyneuropathy preceded by infections. Campylobacter jejuni the most frequent pathogen and its lipopolysaccharide (LPS) induces antibodies cross-reactive with gangliosides. In this study we assessed whether known functional polymorphisms in LPS receptors CD14 Toll-like receptor 4 (TLR4) are associated increased susceptibility for GBS or C. serology related clinical serological features. Comparison of genotypes 242 patients 210 healthy subjects showed that TLR4 did not confer disease were infection.

参考文章(36)
Kathy Triantafilou, Martha Triantafilou, Russell L. Dedrick, A CD14-independent LPS receptor cluster Nature Immunology. ,vol. 2, pp. 338- 345 ,(2001) , 10.1038/86342
Tricia D. LeVan, John W. Bloom, Thomas J. Bailey, Christopher L. Karp, Marilyn Halonen, Fernando D. Martinez, Donata Vercelli, A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity The Journal of Immunology. ,vol. 167, pp. 5838- 5844 ,(2001) , 10.4049/JIMMUNOL.167.10.5838
Nancy C. Arbour, Eva Lorenz, Brian C. Schutte, Joseph Zabner, Joel N. Kline, Michael Jones, Kathy Frees, Janet L. Watt, David A. Schwartz, TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics. ,vol. 25, pp. 187- 191 ,(2000) , 10.1038/76048
C.T. Wittwer, K.M. Ririe, R.V. Andrew, D.A. David, R.A. Gundry, U.J. Balis, The LightCycler: a microvolume multisample fluorimeter with rapid temperature control BioTechniques. ,vol. 22, pp. 176- 181 ,(1997) , 10.2144/97221PF02
Janardan P. Pandey, Christian A. Vedeler, Immunoglobulin KM genes in Guillain-Barré syndrome Neurogenetics. ,vol. 4, pp. 147- 149 ,(2003) , 10.1007/S10048-003-0144-1
Stefan Kiechl, Eva Lorenz, Markus Reindl, Christian J. Wiedermann, Friedrich Oberhollenzer, Enzo Bonora, Johann Willeit, David A. Schwartz, Toll-like Receptor 4 Polymorphisms and Atherogenesis The New England Journal of Medicine. ,vol. 347, pp. 185- 192 ,(2002) , 10.1056/NEJMOA012673
C.W. Ang, H.Ph. Endtz, B.C. Jacobs, J.D. Laman, M.A. de Klerk, F.G.A. van der Meché, P.A. van Doorn, Campylobacter jejuni lipopolysaccharides from Guillain-Barre syndrome patients induce IgG anti-GM1 antibodies in rabbits Journal of Neuroimmunology. ,vol. 104, pp. 133- 138 ,(2000) , 10.1016/S0165-5728(99)00279-9
Ruud P. Kleyweg, Frans G. A. Van Der Meché, Paul I. M. Schmitz, Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle & Nerve. ,vol. 14, pp. 1103- 1109 ,(1991) , 10.1002/MUS.880141111
Jaroslav A. Hubacek, Jan Pit’ha, Zdena Škodová, Vladimír Stanĕk, Rudolf Poledne, C(−260)→T Polymorphism in the Promoter of the CD14 Monocyte Receptor Gene as a Risk Factor for Myocardial Infarction Circulation. ,vol. 99, pp. 3218- 3220 ,(1999) , 10.1161/01.CIR.99.25.3218
Martha Triantafilou, Kathy Triantafilou, Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster Trends in Immunology. ,vol. 23, pp. 301- 304 ,(2002) , 10.1016/S1471-4906(02)02233-0